These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. Failure of valacyclovir for herpes zoster in a moderately immunocompromised HIV-infected patient. Breton G; Bouldouyre MA; Gervais A; Duval X; Longuet P; Leport C; Vildé JL AIDS Patient Care STDS; 2004 May; 18(5):255-7. PubMed ID: 15186709 [TBL] [Abstract][Full Text] [Related]
65. Oliguric acute renal failure following oral valacyclovir therapy. Sugimoto T; Yasuda M; Sakaguchi M; Koyama T; Uzu T; Kashiwagi A; Isshiki K; Kanasaki M QJM; 2008 Feb; 101(2):164-6. PubMed ID: 18180255 [No Abstract] [Full Text] [Related]
66. Comparative study of the efficacy and safety of valaciclovir versus acyclovir in the treatment of herpes zoster. Lin WR; Lin HH; Lee SS; Tsai HC; Huang CK; Wann SR; Chen YS; Chiang SC; Yen MY; Liu YC J Microbiol Immunol Infect; 2001 Jun; 34(2):138-42. PubMed ID: 11456360 [TBL] [Abstract][Full Text] [Related]
67. Oral antivirals for the acute treatment of recurrent herpes labialis. Jensen LA; Hoehns JD; Squires CL Ann Pharmacother; 2004 Apr; 38(4):705-9. PubMed ID: 14966254 [TBL] [Abstract][Full Text] [Related]
68. The comparative effects of famciclovir and valacyclovir on herpes simplex virus type 1 infection, latency, and reactivation in mice. LeBlanc RA; Pesnicak L; Godleski M; Straus SE J Infect Dis; 1999 Sep; 180(3):594-9. PubMed ID: 10438344 [TBL] [Abstract][Full Text] [Related]